JP2024544499A5 - - Google Patents

Info

Publication number
JP2024544499A5
JP2024544499A5 JP2024526888A JP2024526888A JP2024544499A5 JP 2024544499 A5 JP2024544499 A5 JP 2024544499A5 JP 2024526888 A JP2024526888 A JP 2024526888A JP 2024526888 A JP2024526888 A JP 2024526888A JP 2024544499 A5 JP2024544499 A5 JP 2024544499A5
Authority
JP
Japan
Prior art keywords
hfviii
genetically modified
polypeptide according
substituted amino
amino acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024526888A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024544499A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2022/075976 external-priority patent/WO2023092864A1/en
Publication of JP2024544499A publication Critical patent/JP2024544499A/ja
Publication of JP2024544499A5 publication Critical patent/JP2024544499A5/ja
Pending legal-status Critical Current

Links

JP2024526888A 2021-11-25 2022-02-11 遺伝子工学的改変により得られた、分泌能と凝固活性を向上させた組換えヒト第viii因子 Pending JP2024544499A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN2021133004 2021-11-25
CNPCT/CN2021/133004 2021-11-25
PCT/CN2022/075976 WO2023092864A1 (en) 2021-11-25 2022-02-11 Engineered human fviii with enhanced secretion ability and clotting activity

Publications (2)

Publication Number Publication Date
JP2024544499A JP2024544499A (ja) 2024-12-03
JP2024544499A5 true JP2024544499A5 (cg-RX-API-DMAC7.html) 2025-02-10

Family

ID=84487686

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024526888A Pending JP2024544499A (ja) 2021-11-25 2022-02-11 遺伝子工学的改変により得られた、分泌能と凝固活性を向上させた組換えヒト第viii因子

Country Status (5)

Country Link
US (1) US20240254197A1 (cg-RX-API-DMAC7.html)
EP (1) EP4211153A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024544499A (cg-RX-API-DMAC7.html)
CN (3) CN118638211A (cg-RX-API-DMAC7.html)
WO (1) WO2023092864A1 (cg-RX-API-DMAC7.html)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1502921A1 (en) * 2003-07-29 2005-02-02 ZLB Behring GmbH Recombinant mutated human factor VIII (FVIII) with improved stability
EP1985631A1 (en) * 2007-04-20 2008-10-29 LFB Biotechnologies Demannosylated recombinant factor VIII for the treatment of patients with hemophiila A
WO2013123457A1 (en) * 2012-02-15 2013-08-22 Biogen Idec Ma Inc. Recombinant factor viii proteins
HRP20210031T1 (hr) * 2013-06-24 2021-05-14 Weidong, Xiao Pripravci i metode mutantskog faktora viii
US20160311885A1 (en) * 2013-08-14 2016-10-27 Biogen Ma Inc. Recombinant factor viii proteins
ES2819123T3 (es) * 2015-01-30 2021-04-15 Univ Emory Proteínas del factor VIII que tienen secuencias ancestrales, vectores de expresión, y usos relacionados con ellos
CN108884145B (zh) * 2015-11-13 2023-08-22 武田药品工业株式会社 用于血友病a的基因治疗的具有增加的表达的编码重组fviii变体的病毒载体
KR102219859B1 (ko) * 2016-06-24 2021-02-25 재단법인 목암생명과학연구소 재조합 단쇄 fviii 및 그 화학 접합물
JP2020519272A (ja) * 2017-05-09 2020-07-02 エモリー ユニバーシティー 凝固因子変異体及びその使用
TWI851647B (zh) * 2019-01-16 2024-08-11 日商武田藥品工業股份有限公司 用於a型血友病基因治療之編碼表現增加之重組fviii變異體的病毒載體
WO2022165390A1 (en) * 2021-01-29 2022-08-04 Expression Therapeutics, Llc Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use

Similar Documents

Publication Publication Date Title
JP2019506166A5 (cg-RX-API-DMAC7.html)
JP2010516252A5 (cg-RX-API-DMAC7.html)
JP2022519507A5 (cg-RX-API-DMAC7.html)
JP2023518596A5 (cg-RX-API-DMAC7.html)
JP2023544834A5 (cg-RX-API-DMAC7.html)
JP2023524054A5 (cg-RX-API-DMAC7.html)
JP2018138049A5 (cg-RX-API-DMAC7.html)
JP2022513308A5 (cg-RX-API-DMAC7.html)
JP2015521465A5 (cg-RX-API-DMAC7.html)
JP2010519293A5 (cg-RX-API-DMAC7.html)
JP2002500886A5 (cg-RX-API-DMAC7.html)
JP2003530093A5 (cg-RX-API-DMAC7.html)
JP2015501156A5 (cg-RX-API-DMAC7.html)
JP2024041821A5 (cg-RX-API-DMAC7.html)
CN110511280A (zh) 一种透皮重组纤连蛋白及其应用
JP2023545707A5 (cg-RX-API-DMAC7.html)
JP2023179752A5 (cg-RX-API-DMAC7.html)
JP2023528204A5 (cg-RX-API-DMAC7.html)
JP2023554379A5 (cg-RX-API-DMAC7.html)
JP2026035742A5 (cg-RX-API-DMAC7.html)
JP2023522154A5 (cg-RX-API-DMAC7.html)
JP2024503091A5 (cg-RX-API-DMAC7.html)
JP2020517260A5 (cg-RX-API-DMAC7.html)
JP2024537250A5 (cg-RX-API-DMAC7.html)
JP2023544702A5 (cg-RX-API-DMAC7.html)